John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$153M |
| 2 |
LNKD
LinkedIn Corporation
LNKD
|
+$130M |
| 3 |
Cummins
CMI
|
+$121M |
| 4 |
Lowe's Companies
LOW
|
+$104M |
| 5 |
American Express
AXP
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$445M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$200M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$165M |
| 4 |
Gilead Sciences
GILD
|
+$158M |
| 5 |
Microsoft
MSFT
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.25% |
| 2 | Healthcare | 12.59% |
| 3 | Industrials | 11.99% |
| 4 | Financials | 10.09% |
| 5 | Consumer Discretionary | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
CALL
Blackrock
BLK
$182B
| $341K | ﹤0.01% |
+1,000
| New | +$340K |
|
|
ULTI
2177
DELISTED
Ultimate Software Group Inc
ULTI
| $341K | ﹤0.01% |
+1,742
| New | +$341K |
|
|
BCR
2178
DELISTED
CR Bard Inc.
BCR
| $341K | ﹤0.01% |
1,800
-244
| -12% | -$45.7K |
|
2179
Extreme Networks
EXTR
$2.92B
| $340K | ﹤0.01% |
+83,437
| New | +$323K |
|
2180
CALL
Halliburton
HAL
$28.9B
| $340K | ﹤0.01% |
10,000
-95,000
| -90% | -$3.58M |
|
2181
TechTarget
TTGT
$276M
| $339K | ﹤0.01% |
42,158
-7,808
| -16% | -$67.6K |
|
|
ENZ
2182
DELISTED
Enzo Biochem, Inc.
ENZ
| $338K | ﹤0.01% |
+75,058
| New | +$317K |
|
|
ELRC
2183
DELISTED
ELECTRO RENT CORP
ELRC
| $338K | ﹤0.01% |
36,792
+9,881
| +37% | +$102K |
|
2184
PUT
Celanese
CE
$4.97B
| $337K | ﹤0.01% |
+5,000
| New | +$340K |
|
2185
CALL
Eli Lilly
LLY
$1.11T
| $337K | ﹤0.01% |
+4,000
| New | +$332K |
|
|
TBNK
2186
DELISTED
Territorial Bancorp Inc.
TBNK
| $337K | ﹤0.01% |
+12,163
| New | +$342K |
|
|
SNOW
2187
DELISTED
Intrawest Resorts Holdings, Inc.
SNOW
| $336K | ﹤0.01% |
42,976
+29,639
| +222% | +$260K |
|
2188
PUT
Marriott International
MAR
$93.9B
| $335K | ﹤0.01% |
+5,000
| New | +$362K |
|
|
QEP
2189
PUT
DELISTED
QEP RESOURCES, INC.
QEP
| $335K | ﹤0.01% |
+25,000
| New | +$364K |
|
|
GG
2190
PUT
DELISTED
Goldcorp Inc
GG
| $335K | ﹤0.01% |
29,000
-11,000
| -28% | -$140K |
|
2191
PetMed Express
PETS
$37.9M
| $334K | ﹤0.01% |
+19,499
| New | +$328K |
|
2192
NextEra Energy
NEE
$175B
| $333K | ﹤0.01% |
+12,840
| New | +$325K |
|
|
BHBK
2193
DELISTED
Blue Hills Bancorp, Inc.
BHBK
| $332K | ﹤0.01% |
+21,676
| New | +$323K |
|
2194
Ameresco
AMRC
$1.11B
| $331K | ﹤0.01% |
+52,946
| New | +$341K |
|
2195
Consumer Portfolio Services
CPSS
$197M
| $329K | ﹤0.01% |
63,316
+22,179
| +54% | +$114K |
|
2196
CALL
Oracle
ORCL
$410B
| $329K | ﹤0.01% |
9,000
-91,000
| -91% | -$3.48M |
|
2197
CALL
Sysco
SYY
$40.1B
| $328K | ﹤0.01% |
+8,000
| New | +$328K |
|
|
CLCT
2198
DELISTED
Collectors Universe
CLCT
| $328K | ﹤0.01% |
21,166
+5,448
| +35% | +$88.9K |
|
|
HOS
2199
DELISTED
Hornbeck Offshore Services, Inc.
HOS
| $328K | ﹤0.01% |
+33,015
| New | +$423K |
|
2200
KRONOS Worldwide
KRO
$1B
| $327K | ﹤0.01% |
57,948
+32,236
| +125% | +$216K |
|
Similar funds
John Overdeck's Q4 2015 Portfolio in Review
As of Q4 2015, John Overdeck held 3,233 positions worth $20.9B, up 6.8% from $19.5B the previous quarter. Its ten largest holdings account for 8% of the portfolio.
John Overdeck deployed $631M of net new capital in Q4 2015, opening 1,109 new positions and adding to 884 existing holdings. Its largest new stake was American Express: 1,381,273 shares worth $96.1M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $158M trimmed.
- John Overdeck's largest Q4 2015 buy was American Express: 1,381,273 shares worth $96.1M.
- John Overdeck added most to Allergan plc in Q4 2015, an estimated $153M increase.
- John Overdeck's biggest Q4 2015 reduction was Gilead Sciences, cutting an estimated $158M.
- John Overdeck fully exited State Street SPDR S&P 500 ETF Trust in Q4 2015, selling an estimated $445M.
- John Overdeck's ten largest holdings make up 8% of its $20.9B portfolio in Q4 2015.
- John Overdeck opened 1,109 new positions and closed 598 in Q4 2015.
- John Overdeck's portfolio value rose 6.8% quarter-over-quarter to $20.9B.
Based on Two Sigma Investments's 13F filing for Q4 2015, filed 16 Feb 2016.